Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC 
Maithri Drugs: Dedicated to your API needs.
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37597
Submission : 2022-10-21
Status :
Type : II
Maithri Drugs: Dedicated to your API needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37015
Submission : 2022-03-31
Status :
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
Maithri Drugs: Dedicated to your API needs.
Date of Issue : 2024-02-12
Valid Till : 2027-02-11
Written Confirmation Number : WC-0407
Address of the Firm : Sy. No. 205, 222 to 226, IDA Bonthapally, Bonthapally (Village), Gummadidala (Ma...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
Lead Product(s) : Ozanimod,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Wellosia®; Prioritizing our Patients' Well-Being
Details : Wellosia (ozanimod) is a S1P modulator, small molecule drug candidate, which is indicated for the treatment of relapsing forms of multiple sclerosis & moderately to severely active ulcerative colitis.
Product Name : Wellosia
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 02, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.
(S)-1-amino-2,3-dihydro-1H-indene-4-carbonitrile h...
CAS Number : 1306763-57-4
End Use API : Ozanimod
About The Company : Aarti Pharmalabs is generic APIs & Intermediates manufacturing company & small molecule drug substance CDMO and the largest Indian manufacturer of Xanthine Deri...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
04 Sep 2025
// PR NEWSWIRE
22 Jul 2025
// FDA
14 Oct 2024
// EXPRESSPHARMA
18 Sep 2024
// BUSINESSWIRE
05 Jun 2024
// FDA
29 Mar 2024
// REUTERS
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Annual Reports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
15 Sep 2025
Reply
06 Jun 2025
Reply
28 Nov 2024
Reply
26 Sep 2020
Reply
12 Jun 2020
Reply
10 Jun 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
Others
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
100
PharmaCompass offers a list of Ozanimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ozanimod manufacturer or Ozanimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ozanimod manufacturer or Ozanimod supplier.
PharmaCompass also assists you with knowing the Ozanimod API Price utilized in the formulation of products. Ozanimod API Price is not always fixed or binding as the Ozanimod Price is obtained through a variety of data sources. The Ozanimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ozanimod Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ozanimod Hydrochloride, including repackagers and relabelers. The FDA regulates Ozanimod Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ozanimod Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ozanimod Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ozanimod Hydrochloride supplier is an individual or a company that provides Ozanimod Hydrochloride active pharmaceutical ingredient (API) or Ozanimod Hydrochloride finished formulations upon request. The Ozanimod Hydrochloride suppliers may include Ozanimod Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Ozanimod Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ozanimod Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Ozanimod Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Ozanimod Hydrochloride DMFs exist exist since differing nations have different regulations, such as Ozanimod Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ozanimod Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Ozanimod Hydrochloride USDMF includes data on Ozanimod Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ozanimod Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ozanimod Hydrochloride suppliers with USDMF on PharmaCompass.
A Ozanimod Hydrochloride written confirmation (Ozanimod Hydrochloride WC) is an official document issued by a regulatory agency to a Ozanimod Hydrochloride manufacturer, verifying that the manufacturing facility of a Ozanimod Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ozanimod Hydrochloride APIs or Ozanimod Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Ozanimod Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Ozanimod Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ozanimod Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ozanimod Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ozanimod Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ozanimod Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ozanimod Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ozanimod Hydrochloride suppliers with NDC on PharmaCompass.
Ozanimod Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ozanimod Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ozanimod Hydrochloride GMP manufacturer or Ozanimod Hydrochloride GMP API supplier for your needs.
A Ozanimod Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Ozanimod Hydrochloride's compliance with Ozanimod Hydrochloride specifications and serves as a tool for batch-level quality control.
Ozanimod Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Ozanimod Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ozanimod Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Ozanimod Hydrochloride EP), Ozanimod Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ozanimod Hydrochloride USP).
Share 
Comment (1)
